Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors
about
Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@ast
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@en
type
label
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@ast
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@en
prefLabel
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@ast
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@en
P2093
P2860
P1433
P1476
Gastrointestinal cancer cells ...... AKT, HIF-1α and VEGF receptors
@en
P2093
Issam Raad
Joelle El Hajj
Nada Alaaeddine
Ray Hachem
Riad Sarkis
Roula Tahtouh
P2860
P304
P356
10.1371/JOURNAL.PONE.0179202
P407
P577
2017-06-08T00:00:00Z